Evidence map›Paper›PMID 30919010›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2019

Activation of orexinergic and histaminergic pathway involved in therapeutic effect of histamine H

Kouichi Yamamoto, Rikuya Okui, Atsushi Yamatodani

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Hypocretin (Orexin) Replacement Therapies.Medicine in drug discovery · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kouichi YamamotoDepartment of Medical Science and Technology, Division of Health Sciences, Graduate School of Medicine, Osaka University, Yamadaoka 1-7, Suita, Osaka, 565-0871, Japan. kouichi@sahs.med.osaka-u.ac.jp.ORCID 0000-0002-8073-2871
Rikuya OkuiDepartment of Medical Science and Technology, Division of Health Sciences, Graduate School of Medicine, Osaka University, Yamadaoka 1-7, Suita, Osaka, 565-0871, Japan.
Atsushi YamatodaniProfessor Emeritus, Osaka University, Yamadaoka 1-1, Suita, Osaka, 565-0871, Japan.
The University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously reported that hypothalamic tumor necrosis factor-alpha (TNF-α) mRNA expression via histamine H

Indexed as

AnimalsAnorexiaAntineoplastic AgentsCisplatinDioxanesEatingHistamineHistamine AgonistsHistamine AntagonistsImidazolesIndolesMaleMiceMice, Inbred DBAOrexin ReceptorsOrexins1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazineAntineoplastic AgentsciproxifanCisplatinDioxanesHistamineHistamine AgonistsHistamine AntagonistsImidazolesIndolesJNJ 10397049Orexin ReceptorsOrexinsPhenylurea CompoundsPiperazinesReceptors, Histamine H4SB 408124AnorexiaCisplatinHistamine H3 receptorHistamine H4 receptorMiceOrexin OX2 receptor

Identifiers

PMID30919010
OpenAlexW2922997844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.